We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BTAI icon
8201
BioXcel Therapeutics
BTAI
$27.5M
$581K ﹤0.01%
2,747
-235
-8% -$49.4K
LRNZ icon
8202
TrueShares Technology AI & Deep Learning ETF
LRNZ
$42.3M
$581K ﹤0.01%
21,536
+1,599
+8% +$48.1K
ABUS icon
8203
CALL
Arbutus Biopharma
ABUS
$924M
$580K ﹤0.01%
214,100
-68,200
-24% -$175K
QRVO icon
8204
Qorvo
QRVO
$8.66B
$580K ﹤0.01%
6,153
+3,994
+185% +$431K
SBRA icon
8205
CALL
Sabra Healthcare REIT
SBRA
$5.19B
$580K ﹤0.01%
41,500
-19,100
-32% -$255K
FST
8206
PUT
DELISTED
FAST Acquisition Corp.
FST
$580K ﹤0.01%
57,300
-58,500
-51% -$590K
CHGX
8207
DELISTED
AXS Change Finance ESG ETF
CHGX
$580K ﹤0.01%
+22,140
New +$629K
CWEN.A
8208
CALL
DELISTED
Clearway Energy Class A
CWEN.A
$579K ﹤0.01%
18,100
+11,300
+166% +$352K
AQUA
8209
CALL
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
$579K ﹤0.01%
17,800
+4,700
+36% +$179K
PBT
8210
Permian Basin Royalty Trust
PBT
$1.52B
$578K ﹤0.01%
34,899
-50,923
-59% -$790K
SRG
8211
PUT
Seritage Growth Properties
SRG
$128M
$578K ﹤0.01%
111,000
-31,500
-22% -$281K
STXS icon
8212
Stereotaxis
STXS
$138M
$578K ﹤0.01%
314,428
+201,709
+179% +$482K
BNT
8213
Brookfield Wealth Solutions
BNT
$13B
$578K ﹤0.01%
19,434
-4,143
-18% -$138K
RVAC
8214
PUT
DELISTED
Riverview Acquisition Corp. Class A Common Stock
RVAC
$578K ﹤0.01%
+58,100
New +$576K
INZY
8215
DELISTED
Inozyme Pharma
INZY
$577K ﹤0.01%
120,827
+22,530
+23% +$98K
KVSA
8216
CALL
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
$577K ﹤0.01%
59,200
+25,300
+75% +$247K
CLNE icon
8217
CALL
Clean Energy Fuels
CLNE
$403M
$576K ﹤0.01%
128,500
-14,300
-10% -$82.8K
RDN icon
8218
CALL
Radian Group
RDN
$4.98B
$576K ﹤0.01%
29,300
+8,700
+42% +$183K
PRCT icon
8219
PUT
Procept Biorobotics
PRCT
$1.21B
$575K ﹤0.01%
+17,600
New +$640K
TEX icon
8220
PUT
Terex
TEX
$7.7B
$575K ﹤0.01%
21,000
+3,500
+20% +$117K
DJP icon
8221
PUT
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$836M
$574K ﹤0.01%
16,500
-2,400
-13% -$92.8K
NAT icon
8222
PUT
Nordic American Tanker
NAT
$1.42B
$574K ﹤0.01%
269,600
-33,500
-11% -$80K
PAR icon
8223
PAR Technology
PAR
$788M
$574K ﹤0.01%
15,308
-251,275
-94% -$9.03M
SPDW icon
8224
CALL
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$42.2B
$574K ﹤0.01%
19,900
-6,900
-26% -$218K
TNET icon
8225
PUT
TriNet
TNET
$3.16B
$574K ﹤0.01%
7,400
-17,000
-70% -$1.42M

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.